Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice.
Journal: Hepatology communications
Published: August 29, 2017
Using antisense technology to develop a novel therapy for α-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease.
Journal: Rare diseases (Austin, Tex.)
Published: January 27, 2014
Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice.
Journal: The Journal of clinical investigation
Published: November 27, 2012
Showing 1-3 of 3
Last Updated: 09/26/2026